These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31016663)
1. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis. Ramaiahgari SC; Ferguson SS Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663 [TBL] [Abstract][Full Text] [Related]
2. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214 [TBL] [Abstract][Full Text] [Related]
3. From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells. Burbank MG; Sharanek A; Burban A; Mialanne H; Aerts H; Guguen-Guillouzo C; Weaver RJ; Guillouzo A Toxicol Sci; 2017 Jun; 157(2):451-464. PubMed ID: 28369585 [TBL] [Abstract][Full Text] [Related]
4. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057 [TBL] [Abstract][Full Text] [Related]
6. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes. Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665 [TBL] [Abstract][Full Text] [Related]
7. High-Throughput Screening to Evaluate Inhibition of Bile Acid Transporters Using Human Hepatocytes Isolated From Chimeric Mice. Kohara H; Bajaj P; Yamanaka K; Miyawaki A; Harada K; Miyamoto K; Matsui T; Okai Y; Wagoner M; Shinozawa T Toxicol Sci; 2020 Feb; 173(2):347-361. PubMed ID: 31722436 [TBL] [Abstract][Full Text] [Related]
8. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury. Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619 [TBL] [Abstract][Full Text] [Related]
9. Setup and Use of HepaRG Cells in Cholestasis Research. Guguen-Guillouzo C; Guillouzo A Methods Mol Biol; 2019; 1981():291-312. PubMed ID: 31016662 [TBL] [Abstract][Full Text] [Related]
10. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies. Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895 [TBL] [Abstract][Full Text] [Related]
11. Bile canaliculi formation and biliary transport in 3D sandwich-cultured hepatocytes in dependence of the extracellular matrix composition. Deharde D; Schneider C; Hiller T; Fischer N; Kegel V; Lübberstedt M; Freyer N; Hengstler JG; Andersson TB; Seehofer D; Pratschke J; Zeilinger K; Damm G Arch Toxicol; 2016 Oct; 90(10):2497-511. PubMed ID: 27325308 [TBL] [Abstract][Full Text] [Related]
12. Ex Vivo Model in Cholestasis Research. Karsten REH; Oosterhuis D; van Wijk LA; Olinga P Methods Mol Biol; 2019; 1981():351-362. PubMed ID: 31016666 [TBL] [Abstract][Full Text] [Related]
13. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease. Stieger B; Mahdi ZM J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542 [TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes. Burban A; Sharanek A; Guguen-Guillouzo C; Guillouzo A Free Radic Biol Med; 2018 Feb; 115():166-178. PubMed ID: 29191461 [TBL] [Abstract][Full Text] [Related]
15. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis. Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918 [TBL] [Abstract][Full Text] [Related]
16. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review. Cheng Y; Woolf TF; Gan J; He K Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212 [TBL] [Abstract][Full Text] [Related]
17. From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening. Ramaiahgari SC; Waidyanatha S; Dixon D; DeVito MJ; Paules RS; Ferguson SS Toxicol Sci; 2017 Sep; 159(1):124-136. PubMed ID: 28633424 [TBL] [Abstract][Full Text] [Related]
18. Formation of functional, extended bile canaliculi, and increased bile acid production in sandwich-cultured human cryopreserved hepatocytes using commercially available culture medium. Horiuchi S; Kuroda Y; Oyafuso R; Komizu Y; Maeda K; Ishida S Arch Toxicol; 2024 Aug; 98(8):2605-2617. PubMed ID: 38753187 [TBL] [Abstract][Full Text] [Related]
19. Sandwich-cultured rat hepatocytes as an in vitro model to study canalicular transport alterations in cholestasis. Miszczuk GS; Barosso IR; Zucchetti AE; Boaglio AC; Pellegrino JM; Sánchez Pozzi EJ; Roma MG; Crocenzi FA Arch Toxicol; 2015 Jun; 89(6):979-90. PubMed ID: 24912783 [TBL] [Abstract][Full Text] [Related]
20. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump. Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]